This was further supported by the negative impact on selenium and its ability to stimulate p53 and induce apoptosis in leukemia CSCs in the presence of nonsteroidal anti-inflammatory agents (NSAIDs, e.g., indomethacin) and NADPH oxidase inhibitors. Here, TP53 is linked to leukemia.